Humira

Humira's Sales Will Decline -- and It's Fantastic News for AbbVie
Humira's Sales Will Decline -- and It's Fantastic News for AbbVie
Motley Fool
Humira
AbbVie
biosimilars
Flag link:
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
Fierce Pharma
Humira
AbbVie
Keytruda
Merck
Revlimid
Celgene
Opdivo
Bristol-Myers Squibb
Flag link:
How Novartis, Insurers Are Taking Wind Out Of AbbVie's Sales
How Novartis, Insurers Are Taking Wind Out Of AbbVie's Sales
Investors Business Daily
AbbVie
Novartis
Humira
biosimilars
Europe
CHMP
Flag link:
Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands
Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands
Fierce Pharma
AbbVie
Pfizer
television ads
DTC ads
Humira
Lyrica
Flag link:
AbbVie's First Quarter: Trying to Replace Humira Sales
AbbVie's First Quarter: Trying to Replace Humira Sales
Yahoo/Motley Fool
AbbVie
earnings
Humira
Flag link:
Could Oral Biosimilars of Humira and Embrel Disrupt the Biologics Market?
Could Oral Biosimilars of Humira and Embrel Disrupt the Biologics Market?
Xtalks
biosimilars
Rani Therapeutics
Humira
Embrel
Flag link:
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
CP Wire
Humira
Mylan
Fujifilm
AbbVie
biosimilars
FKB327
Flag link:
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
Humira
Mylan
Fujifilm
Flag link:
With study success, AbbVie's arthritis hopeful looks to be a safer bet
With study success, AbbVie's arthritis hopeful looks to be a safer bet
Biopharma Dive
AbbVie
rheumatoid arthritis
Upadacitinib
Humira
clinical trials
Flag link:
$21B or bust! AbbVie ensures its blockbuster US marathon on Humira will run into 2023
$21B or bust! AbbVie ensures its blockbuster US marathon on Humira will run into 2023
Endpoints
AbbVie
Humira
biosimilars
Flag link:
Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica
Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica
Fierce Pharma
Pfizer
Ibrance
television ads
Humira
AbbVie
DTC advertising
Lyrica
Flag link:
5 Must-See Quotes From AbbVie's Management
5 Must-See Quotes From AbbVie's Management
Yahoo/Motley Fool
AbbVie
Humira
hepatitis C
Mavyret
Viekira
M&A
Flag link:
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
AbbVie
Roche
Humira
Rituxan
Herceptin
Avastin
Flag link:
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Flag link:
Novartis aims for US approval of Humira biosimilar
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Novartis
Humira
biosimilars
AbbVie
Sandoz
Flag link:
Here's How AbbVie Inc. Crushed It in 2017
Here's How AbbVie Inc. Crushed It in 2017
Yahoo/Motley Fool
AbbVie
biosimilars
Humira
Imbruvica
Flag link:
The 2018 biosimilar litigation landscape: A primer
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Flag link:
Boehringer wins EU approval for Humira biosimilar
Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie
Flag link:
7 Things AbbVie's Top Executives Just Said That You'll Want to Know
7 Things AbbVie's Top Executives Just Said That You'll Want to Know
Motley Fool
AbbVie
Humira
Imbruvica
Venclexta
Amazon
tax reform
Flag link:
Could pain data give Lilly's baricitinib back its edge?
Could pain data give Lilly's baricitinib back its edge?
BioPharma Dive
Eli Lilly
baricitinib
Humira
AbbVie
rheumatoid arthritis
Flag link:

Pages